Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
PRESS RELEASE: National investment agenda aims to position the Netherlands as a global leader in industrial biotechnology
Seven organisations from the Delft biotech ecosystem have presented the national investment agenda 'Biotech op Schaal' to the Dutch Minister of Economic Affairs. The €335 million investment programme aims to strengthen the Netherlands' industrial biotechnology ecosystem by expanding scale-up infrastructure, accelerating commercialisation and reinforcing the country's international competitiveness.
Fermentify joins Planet B.io to make plant-based food taste as good as the original
Fermentify has joined Planet B.io's Flexible Bio Lab to develop precision-fermented ingredients that make plant-based foods taste and feel just as good as their animal-based counterparts.
Join Planet B.io at Bio Innovations Europe 2026 – Exclusive 25% discount
We’re happy to be part of the Dutch Biotech Cluster at Bio Innovations Europe 2026, alongside Biotech Booster and hollandbio! Taking place in The Hague on 10-11 June and focused on driving the commercialisation of industrial biomanufacturing in Europe, Bio Innovations Europe will connect over 400 bio-pioneers from across the region for two days of pre-arranged, commercially focused 1-2-1 meetings, knowledge exchange and networking.